Advancements in Vaccine Research and Development
This session explores the latest breakthroughs in vaccine development, from preclinical research to clinical trials. Leading experts will discuss novel vaccine platforms, including mRNA and DNA vaccines, as well as advancements in adjuvants and delivery systems. Attendees will gain insights into overcoming challenges in vaccine efficacy, stability, and safety, along with the regulatory hurdles faced during development. Special focus will be given to the rapid development of vaccines for emerging infectious diseases, including lessons learned from the COVID-19 pandemic.
Related Conference of Advancements in Vaccine Research and Development
March 24-25, 2026
9th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
Advancements in Vaccine Research and Development Conference Speakers
Recommended Sessions
- Translational Immunology and Vaccine Development
- Advancements in Vaccine Research and Development
- Advances in Pediatric Vaccines
- Clinical Trials Design and Methodologies
- Emerging Infectious Diseases and Vaccine Development
- Ethical Considerations in Vaccine Development and Distribution
- Global Immunization Strategies and Policy
- Immunology of Infectious Diseases
- Immunotherapy and Personalized Medicine
- Innovations in Vaccine Cold Chain and Storage
- Regulatory Approaches in Vaccine Development
- Role of Adjuvants in Vaccine Efficacy
- Role of AI and Big Data in Vaccine Research
- Vaccine Delivery Systems: Innovations and Challenges
- Vaccine Development for Cancer Immunotherapy
- Vaccine Development for Vector-Borne Diseases
- Vaccine Equity and Access in Low-Resource Settings
- Vaccine Hesitancy and Public Perception
- Vaccine Manufacturing and Distribution
- Vaccine Safety and Pharmacovigilance
Related Journals
Are you interested in
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2025 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2025 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- DNA Vaccines - Euro Vaccines 2025 (France)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- Hepatitis Vaccines - Euro Vaccines 2025 (France)
- HIV/AIDS Vaccines - Euro Vaccines 2025 (France)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2025 (France)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2025 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunology/Animal Models - Euro Vaccines 2025 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Mucosal Vaccines - Euro Vaccines 2025 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2025 (France)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Vaccine Adjuvants - Euro Vaccines 2025 (France)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Research & Development - Euro Vaccines 2025 (France)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2025 (France)
- Vaccines Business Development - Euro Vaccines 2025 (France)
- Vaccines for Older Adults - Euro Vaccines 2025 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2025 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2025 (France)
- Vaccines Safety & Efficacy - Euro Vaccines 2025 (France)
- Veterinary Vaccines - Euro Vaccines 2025 (France)